Inositol nicotinate crystalline form A and preparation method therefor
AssigneeWeifang Shengyu Pharma Co., Ltd.
InventorsLiwei Zhu, Xuefeng Mei, Jianrong Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeWeifang Shengyu Pharma Co., Ltd.
InventorsLiwei Zhu, Xuefeng Mei, Jianrong Wang
Estimating the term…
Provided are an inositol nicotinate crystalline form A and a preparation method therefor. The X-ray powder diffraction analysis, obtained by using Cu-Kα ray measurement, of the inositol nicotinate crystalline form A has obvious characteristic diffraction peaks at least at 2θ values, expressed in degrees, of 7.05, 7.41, 9.74, 17.80, 19.86, 23.57, 25.48 and 26.20 with an error range of +/−0.2°. The preparation method is one of or a mixed crystallization method of two or more of an evaporation crystallization method, a cooling crystallization method or an anti-solvent crystallization method. The process thereof is simple and easy to operate, and has more selectivity; the inositol nicotinate crystalline form A can be prepared by various methods, and the prepared product has a good crystallization degree and high chemical stability; and the inositol nicotinate crystalline form A prepared by the present method does not have the problem that a residual solvent is out-of-limit.
A crystal form A of inositol nicotinate, wherein X-ray powder diffraction analysis of the crystal form A obtained using Cu-Kα ray measurement, with an error range of ±0.2°, has characteristic diffraction peaks at 7.05, 7.41, 9.74, 17.80, 19.86, 23.57, 25.48 and 26.20 of 2θ value expressed as degrees, with an error range of ±0.2°.
Dependencies are inferred from the claim text.